STM Journals Peer-reviewed research from Consortium e-Learning Network

International Journal of Genetic Modifications and Recombinations Review Article

Stretching Boundaries: A Comprehensive Review of Ehlers-Danlos Syndrome and its Subtypes

  1. Sameer Sheth Department of Pharmacy, Dr. D.Y. Patil Institute Of Pharmaceutical Sciences and Research
  2. Isha Oturkar Department of Pharmacy, Dr. D.Y. Patil Institute Of Pharmaceutical Sciences and Research
  3. Dr. Midhun Kizhakethil Department of Pharmacy, Dr. D.Y. Patil Institute Of Pharmaceutical Sciences and Research

Abstract

The Ehlers-Danlos syndromes (EDS) encompass 13 inheritable disorders affecting connective tissue. These conditions arise from genetic alterations impacting the structure of connective tissue. Every variant of Ehlers-Danlos syndrome (EDS) exhibits distinct features and has specific diagnostic criteria. While certain traits such as joint hypermobility, skin hyperextensibility, and tissue fragility are common across all types of EDS. The range of clinical presentations spans from minor skin and joint looseness to severe physical impairment and potentially life-threatening vascular issues. The current Villefranche classification identifies six subtypes, many of which are associated with mutations in genes responsible for fibrillar collagens or enzymes engaged in the post-translational modification of these proteins. Classic or vascular EDS results from mutations in type V and type III collagen respectively, while mutations affecting the processing of type I collagen contribute to kyphoscoliosis, arthrochalasis, and dermatosparaxis types of EDS. The list of conditions included in the process of differential diagnosis for Ehlers-Danlos syndrome (EDS) encompasses fibromyalgia, autosomal dominant polycystic kidney disease, Marfan syndrome, hypermobility spectrum disorders, chronic fatigue syndrome, osteogenesis Imperfecta Type 1, Cutis laxa syndromes, Loey-Dietz syndrome, and depression. This review investigates Ehlers-Danlos syndrome (EDS), encompassing its diverse subtypes, genetic origins, pathophysiology, clinical manifestations, and diagnostic protocols. It sheds light on the intricate challenges faced by individuals with EDS due to the unpredictable symptomatology. The review underscores the necessity for holistic care paradigms to address the multifaceted needs of EDS patients, aiming to advance both clinical understanding and management strategies for this complex disorder.

Keywords

References (47)

  1. Malfait F, De Paepe A. The Ehlers-Danlos Syndrome. Advances in Experimental Medicine and Biology. 2013:129-143. doi:10.1007/978-94-007-7893-1_9
  2. Steinmann B, Royce PM, Superti‐Furga A. The Ehlers‐Danlos Syndrome. Connective Tissue and Its Heritable Disorders. 2002:431-523. doi:10.1002/0471221929.ch9
  3. Islam M, Chang C, Gershwin ME. Ehlers-Danlos Syndrome: Immunologic contrasts and connective tissue comparisons. Journal of Translational Autoimmunity. 2021;4:100077. doi:10.1016/j.jtauto.2020.100077
  4. (n.d.). UpToDate. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-ehlers-danlos-syndromes
  5. Miklovic, T., & Sieg, V. C. (2023, May 29). Ehlers-Danlos Syndrome. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK549814//
  6. Palomo-Toucedo I, Leon-Larios F, Reina-Bueno M, Vázquez-Bautista M, Munuera-Martínez P, Domínguez-Maldonado G. Psychosocial Influence of Ehlers–Danlos Syndrome in Daily Life of Patients: A Qualitative Study. International Journal of Environmental Research and Public Health. 2020;17(17):6425. doi:10.3390/ijerph17176425
  7. Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers–Danlos syndromes. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2017;175(1):8-26. doi:10.1002/ajmg.c.31552
  8. Guarnieri V, Morlino S, Di Stolfo G, Mastroianno S, Mazza T, Castori M. Cardiac valvular Ehlers‐Danlos syndrome is a well‐defined condition due to recessive null variants in COL1A2. American Journal of Medical Genetics Part A. 2019;179(5):846-851. doi:10.1002/ajmg.a.61100
  9. Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and Genetic Features of Ehlers–Danlos Syndrome Type IV, the Vascular Type. New England Journal of Medicine. 2000;342(10):673-680. doi:10.1056/nejm200003093421001
  10. Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, et al. Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural history. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2017;175(1):48-69. doi:10.1002/ajmg.c.31538
  11. Blackburn PR, Xu Z, Tumelty KE, Zhao RW, Monis WJ, Harris KG, et al. Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos Syndrome. The American Journal of Human Genetics. 2018;102(4):696-705. doi:10.1016/j.ajhg.2018.02.018
  12. Colige A, Nuytinck L, Hausser I, van Essen AJ, Thiry M, Herens C, et al. Novel Types of Mutation Responsible for the Dermatosparactic Type of Ehlers–Danlos Syndrome (Type VIIC) and Common Polymorphisms in the ADAMTS2 Gene. Journal of Investigative Dermatology. 2004;123(4):656-663. doi:10.1111/j.0022-202x.2004.23406.x
  13. Yeowell, H. N., & Steinmann, B. (2018, October 18). PLOD1-Related kyphoscoliotic Ehlers-Danlos Syndrome. GeneReviews® - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK1462/#:~:text=PLOD1%2Drelated%20kEDS%20is%20rare,births%20is%20a%20reasonable%20estimate.
  14. Burkitt Wright EM, Porter LF, Spencer HL, Clayton-Smith J, Au L, Munier FL, et al. Brittle cornea syndrome: recognition, molecular diagnosis and management. Orphanet Journal of Rare Diseases. 2013;8(1). doi:10.1186/1750-1172-8-68
  15. Symoens S, Syx D, Malfait F, Callewaert B, De Backer J, Vanakker O, et al. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria. Human Mutation. 2012;33(10):1485-1493. doi:10.1002/humu.22137
  16. Zou Y, Zwolanek D, Izu Y, Gandhy S, Schreiber G, Brockmann K, et al. Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice. Human Molecular Genetics. 2013;23(9):2339-2352. doi:10.1093/hmg/ddt627
  17. Kapferer-Seebacher I, Pepin M, Werner R, Aitman TJ, Nordgren A, Stoiber H, et al. Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S , which Encode Subcomponents C1r and C1s of Complement. The American Journal of Human Genetics. 2016;99(5):1005-1014. doi:10.1016/j.ajhg.2016.08.019
  18. Miklovic, T., & Sieg, V. C. (2023b, May 29). Ehlers-Danlos Syndrome. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK549814/#:~:text=Introduction,and%20fragility%20of%20blood%20vessels
  19. Malfait F, Wenstrup RJ, De Paepe A. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genetics in Medicine. 2010;12(10):597-605. doi:10.1097/gim.0b013e3181eed412
  20. De Paepe A, Malfait F. The Ehlers–Danlos syndrome, a disorder with many faces. Clinical Genetics. 2012;82(1):1-11. doi:10.1111/j.1399-0004.2012.01858.x
  21. Eder, J., Laccone, F., Rohrbach, M., Giunta, C., Aumayr, K., Reichel, C., & Trautinger, F. (2013b). A new COL3A1 mutation in Ehlers–Danlos syndrome type IV. Experimental Dermatology, 22(3), 231–234. https://doi.org/10.1111/exd.12105
  22. Ghali N, Baker D, Brady AF, Burrows N, Cervi E, Cilliers D, et al. Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers–Danlos syndrome with a consistent phenotype of tissue fragility and skin hyperextensibility. Genetics in Medicine. 2019;21(9):2081-2091. doi:10.1038/s41436-019-0470-9
  23. Schwarze U, Atkinson M, Hoffman GG, Greenspan DS, Byers PH. Null Alleles of the COL5A1 Gene of Type V Collagen Are a Cause of the Classical Forms of Ehlers-Danlos Syndrome (Types I and II). The American Journal of Human Genetics. 2000;66(6):1757-1765. doi:10.1086/302933
  24. . Hakim, A. (2024, February 22). Hypermobile Ehlers-Danlos Syndrome. GeneReviews® - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK1279/
  25. Castori M, Camerota F, Celletti C, Grammatico P, Padua L. Ehlers–Danlos syndrome hypermobility type and the excess of affected females: Possible mechanisms and perspectives. American Journal of Medical Genetics Part A. 2010;152A(9):2406-2408. doi:10.1002/ajmg.a.33585
  26. Dolan AL, Arden NK, Grahame R, Spector TD. Assessment of bone in Ehlers Danlos syndrome by ultrasound and densitometry. Annals of the Rheumatic Diseases. 1998;57(10):630-633. doi:10.1136/ard.57.10.630
  27. Wenstrup RJ, Meyer RA, Lyle JS, Hoechstetter L, Rose PS, Levy HP, et al. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. Genetics in Medicine. 2002;4(3):112-117. doi:10.1097/00125817-200205000-00003
  28. Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1116/
  29. Frank M, Albuisson J, Ranque B, Golmard L, Mazzella JM, Bal-Theoleyre L, et al. The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers–Danlos syndrome. European Journal of Human Genetics. 2015;23(12):1657-1664. doi:10.1038/ejhg.2015.32
  30. Rana M, Aziz O, Purkayastha S, Lloyd J, Wolfe J, Ziprin P. Colonoscopic perforation leading to a diagnosis of Ehlers Danlos syndrome type IV: a case report and review of the literature. Journal of Medical Case Reports. 2011;5(1). doi:10.1186/1752-1947-5-229
  31. The Ehlers-Danlos Support UK. (2017, August 29). Kyphoscoliotic Ehlers-Danlos syndrome. https://www.ehlers-danlos.org/information/kyphoscoliotic-ehlers-danlos-syndrome/
  32. Beighton, P., De Paepe, A., Steinmann, B., Tsipouras, P., & Wenstrup, R. (1998). Ehlers‐Danlos syndromes: Revised nosology, Villefranche, 1997. American Journal of Medical Genetics, 77(1), 31–37. https://doi.org/10.1002/(sici)1096-8628(19980428)77:1
  33. Bowen JM, Sobey GJ, Burrows NP, Colombi M, Lavallee ME, Malfait F, et al. Ehlers–Danlos syndrome, classical type. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2017;175(1):27-39. doi:10.1002/ajmg.c.31548
  34. Ritelli M, Dordoni C, Venturini M, Chiarelli N, Quinzani S, Traversa M, et al. Clinical and molecular characterization of 40 patients with classic Ehlers–Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations. Orphanet Journal of Rare Diseases. 2013;8(1). doi:10.1186/1750-1172-8-58
  35. Joseph AW, Joseph SS, Francomano CA, Kontis TC. Characteristics, Diagnosis, and Management of Ehlers-Danlos Syndromes. JAMA Facial Plastic Surgery. 2018;20(1):70-75. doi:10.1001/jamafacial.2017.0793
  36. Byers PH, Belmont J, Black J, De Backer J, Frank M, Jeunemaitre X, et al. Diagnosis, natural history, and management in vascular Ehlers–Danlos syndrome. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2017;175(1):40-47. doi:10.1002/ajmg.c.31553
  37. Bowen JM, Sobey GJ, Burrows NP, Colombi M, Lavallee ME, Malfait F, et al. Ehlers–Danlos syndrome, classical type. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2017;175(1):27-39. doi:10.1002/ajmg.c.31548
  38. Malek S, Reinhold EJ, Pearce GS. The Beighton Score as a measure of generalised joint hypermobility. Rheumatology International. 2021;41(10):1707-1716. doi:10.1007/s00296-021-04832-4
  39. Miklovic T, Sieg VC. Ehlers-Danlos Syndrome. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549814/
  40. Malfait F, Wenstrup RJ, De Paepe A. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genetics in Medicine. 2010;12(10):597-605. doi:10.1097/gim.0b013e3181eed412
  41. Wallman D, Weinberg J, Hohler AD. Ehlers–Danlos Syndrome and Postural Tachycardia Syndrome: A relationship study. Journal of the Neurological Sciences. 2014;340(1-2):99-102. doi:10.1016/j.jns.2014.03.002
  42. Zhang W, Windsor K, Jones R, Taunton DO. Hypermobile type Ehlers‐Danlos syndrome associated with hypogammaglobulinemia and fibromyalgia: A case‐based review on new classification, diagnosis, and multidisciplinary management. Clinical Case Reports. 2019;7(4):680-685. doi:10.1002/ccr3.2070
  43. Fajardo-Jiménez MJ, Tejada-Moreno JA, Mejía-García A, Villegas-Lanau A, Zapata-Builes W, Restrepo JE, et al. Ehlers-Danlos: A Literature Review and Case Report in a Colombian Woman with Multiple Comorbidities. Genes. 2022;13(11):2118. doi:10.3390/genes13112118
  44. Zilocchi M, Macedo TA, Oderich GS, Vrtiska TJ, Biondetti PR, Stanson AW. Vascular Ehlers-Danlos Syndrome: Imaging Findings. American Journal of Roentgenology. 2007;189(3):712-719. doi:10.2214/ajr.07.2370
  45. Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, et al. Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural history. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2017;175(1):48-69. doi:10.1002/ajmg.c.31538
  46. Radiological images of a 14-year-old boy with PLOD1-related. . . (n.d.). ResearchGate. https://www.researchgate.net/figure/Radiological-images-of-a-14-year-old-boy-with-PLOD1-related-kyphoscoliotic-Ehlers-Danlos_fig1_339881957
  47. Zhang W, Windsor K, Jones R, Taunton DO. Hypermobile type Ehlers‐Danlos syndrome associated with hypogammaglobulinemia and fibromyalgia: A case‐based review on new classification, diagnosis, and multidisciplinary management. Clinical Case Reports. 2019;7(4):680-685. doi:10.1002/ccr3.2070